Filter
4526
Filtered Results: 4526
Text search:
resistan
Featured
Recommendations
437
New Publications
1125
Language
Document type
No document type
2381
Guidelines
684
Studies & Reports
679
Manuals
221
Strategic & Response Plan
161
Fact sheets
151
Training Material
78
Situation Updates
38
Infographics
37
Online Courses
34
Resource Platforms
23
Videos
20
Brochures
18
Dashboards/Maps
1
Countries / Regions
India
187
Global
153
Kenya
104
South Africa
99
Western and Central Europe
95
Latin America and the Carribbean
86
Sierra Leone
79
Liberia
79
Uganda
71
Ethiopia
68
Africa
67
Nepal
61
Tanzania
55
Nigeria
54
Eastern Europe
54
Myanmar / Burma
52
Bangladesh
47
Zambia
45
Colombia
43
Rwanda
43
Malawi
41
Congo, Democratic Republic of
37
Paraguay
37
Ghana
36
Venezuela
36
Philippines
35
Indonesia
35
Peru
31
Argentina
31
Ukraine
29
Asia
28
Senegal
27
Guinea
27
Russia
27
Namibia
27
Cambodia
26
South–East Asia Region
26
Syria
23
Zimbabwe
23
Lesotho
20
Cameroon
20
Mozambique
20
Bolivia
19
Germany
17
West and Central Africa
17
Chile
16
Haiti
16
Central African Republic
15
Botswana
15
El Salvador
14
East and Southern Africa
14
Burkina Faso
13
Middle East and North Africa
13
Eastern Europe and Central Asia
13
Brazil
13
South Sudan
13
Pakistan
11
Western Pacific Region
10
Ecuador
10
Eswatini/ Swaziland
10
Thailand
9
Afghanistan
9
Spain
9
Vietnam
9
Tajikistan
8
Benin
8
Albania
8
Mali
8
Iraq
8
USA
7
Lebanon
7
Yemen
7
Georgia
7
Madagascar
7
China
6
Sudan
6
Somalia
6
Laos
5
Côte d’Ivoire / Ivory Coast
5
North Macedonia
4
Mexico
4
Armenia
4
Jordan
4
Uruguay
4
Sri Lanka
4
Honduras
4
Guatemala
4
Serbia
3
Kazakhstan
3
Iran
3
France
3
United Kingdom
3
Southern Africa
3
Angola
3
Bhutan
3
Timor Leste/ East Timor
2
Turkey
2
Estonia
2
Burundi
2
Morocco
2
Guinea-Bissau
2
Saudi Arabia
2
Gabon
2
Japan
2
Mauritius
2
Tunisia
2
Papua New Guinea
2
Moldova
2
Libya
2
Switzerland
1
Gambia
1
Togo
1
Canada
1
Fiji
1
Singapore
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Qatar
1
Dominican Republic
1
Lithuania
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
Maldives
1
Portugal
1
Azerbaijan
1
Belarus
1
Israel
1
Latvia
1
Nicaragua
1
Egypt
1
Greece
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
1525
Clinical Guidelines
424
Public Health
230
Key Resources
185
Women & Child Health
148
Capacity Building
70
Pharmacy & Technologies
60
Annual Report MEDBOX
3
Toolboxes
TB
604
AMR
601
HIV
374
COVID-19
247
Mental Health
194
Planetary Health
156
Rapid Response
147
NTDs
131
Ebola
122
Caregiver
100
Pharmacy
90
Global Health Education
70
Refugee
60
Conflict
59
Disability
58
NCDs
57
Natural Hazards
51
Cholera
38
Health Financing Toolbox
29
Polio
26
Zika
23
Social Ethics
19
Specific Hazards
16
South Sudan
1
Health Financing
1
The Ghanaian Cabinet approved the antimicrobial resistance (AMR)Policy and Implementation plan(hereafter referred to as the national action plan or NAP)in December 2017, whilst the country case study was in progress. This has set in motion the implementation phase for Ghana, which is a long awaited...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
Le présent document de travail a été conçu pour offrir des conseils pratiqueset des suggestions sur la manièred’établir et de maintenir la collaboration multisectorielle nécessaire pour élaborer et mettre en œuvre les plans d’action nationaux (PAN) de lutte contre la RAM. Il s’adresse...
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b...
Nosocomial infections and antimicrobial resistance are two special health issues listed in Annex 1 of Commission Decision 2000/96/EC of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No 2119/98/EC of the European Parliament and of th...
This course is designed for anyone with an interest in antibiotic resistance, no matter if you are a member of the public, a student, a health professional or any other expert.
Our focus is to provide an overview of antibiotic resistance from several different angles. An important aim is to give an...
While infections that develop during hospitalization may appear to be an uncommon but recognized risk of hospital care today, the incidence of these infections has been increasing dramatically during the last 2 to 3 decades, and the risk of acquiring an organism that is resistant to 1 or more antibi...
A short movie about the history and the current status of antibiotics from the four week online course: Antibiotic Resistance: the silent tsunami, produced by ReAct and Uppsala University, Sweden.
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
Stenotrophomonas maltophiliais a nonfermenting Gram-negative rod that is ubiquitous in nature (predominantly occurring in aquatic environments and on plants). Biochemically, it iscatalase positive and oxidase negative, and it produces acid frommaltose (hence the name“maltophilia”). Due to it...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ...
The Global Antibiotic Resistance Partnership (GARP) aims to address the challenge of antibiotic resistance by developing actionable Policy Proposals in Vietnam and four other low- and middle-income countries: China, India, Kenya and South Africa. GARP will develop the evidence base for Policy action...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re...
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis...
